Fekade Bruck Sime1,2, Jason A Roberts1,2,3,4,5. 1. a Burns, Trauma & Critical Care Research Centre , The University of Queensland , Brisbane , Queensland , Australia. 2. b Department of Molecular and Clinical Pharmacology , University of Liverpool , Liverpool , UK. 3. c Department of Intensive Care Medicine , Royal Brisbane and Women's Hospital , Brisbane , Queensland , Australia. 4. d Pharmacy Department , Royal Brisbane and Women's Hospital , Brisbane , Queensland , Australia. 5. e School of Pharmacy , The University of Queensland , Brisbane , Queensland , Australia.
Authors: Christian Nusshag; Markus A Weigand; Martin Zeier; Christian Morath; Thorsten Brenner Journal: Int J Mol Sci Date: 2017-06-28 Impact factor: 5.923